Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade, grantg2, Big_Money_Upward
Search This Board:
Last Post: 9/17/2014 3:54:40 PM - Followers: 275 - Board type: Free - Posts Today: 7
NYSE now, upgraded from OTC!    

This company is 3D bioprinting. That means working towards printing human organs, using stems cells and such as ink.     


 As of Thu, Jul 11, 2013, ONVO trades on NYSE Amex. 

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.

ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact:
Media Contact:

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit


Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.



World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  

   Organovo Support Chart

NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Statement of Changes in Beneficial Ownership (4) 09/16/2014 07:01:04 PM
ONVO News: Current Report Filing (8-k) 09/15/2014 08:05:43 AM
ONVO News: Current Report Filing (8-k) 09/11/2014 08:05:00 AM
ONVO News: Organovo to Present at the Morgan Stanley Global Healthcare Conference 09/05/2014 08:05:00 AM
ONVO News: Statement of Changes in Beneficial Ownership (4) 08/28/2014 07:46:52 PM
#6303  Sticky Note 3D BioPrinter ==='s Print a kidney! Big_Money_Upward 06/27/14 12:54:46 PM
#6278  Sticky Note ONVO news: "Organovo Reports Positive Results from a rayank 06/26/14 10:25:47 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#6865   Thnx for the advice!.. Rdhoughton 09/17/14 01:58:00 PM
#6864   Ohh will they chase when it does! News jjh573 09/17/14 01:57:05 PM
#6863   Smart bottom sight. closing in on the sales dshade 09/17/14 01:56:01 PM
#6862   It was easy to pick up shares in RallyTheMarket 09/17/14 12:33:21 PM
#6861   Picking up shares here all day.. Easy. People Rdhoughton 09/17/14 12:23:11 PM
#6860   could be. this is also Russel Index beholding dshade 09/17/14 08:40:14 AM
#6859   I think that folks are easing out of RandolRocketman 09/16/14 11:24:16 PM
#6858   pick your spots. time will come dshade 09/16/14 02:26:47 PM
#6857   What's Really Holding the Market Back? Is_it_the_coming FinancialArmageddon? rumper 09/16/14 01:34:51 PM
#6856   If_shorting 25%_of_the_float isn't_overdone, What_is? rumper 09/16/14 01:23:45 PM
#6855   We are here picking our spots on these dshade 09/16/14 11:46:32 AM
#6854   That's the $64k question. We surveyed 100 ONVO RallyTheMarket 09/16/14 11:44:20 AM
#6853   Where's everyone at? Is this bottom for ONVO? HennHouse 09/16/14 11:28:04 AM
#6852   being in the R Index can be a pain dshade 09/15/14 04:07:32 PM
#6851   Gee, a_lot_of Sep 20 calls will expire worthless. rumper 09/15/14 11:51:53 AM
#6850   read 8-k today. they updated the frequesntly asked dshade 09/15/14 10:34:46 AM
#6849   Organovo sued and won rumper 09/15/14 10:28:19 AM
#6848   yep, all over the place it occurs. dshade 09/15/14 10:05:17 AM
#6847   sounds like the guy got away with the 2014trader 09/15/14 10:03:43 AM
#6846   almost at that July low pre bounce dshade 09/15/14 09:55:35 AM
#6845   Organovo sued and won its case. Simeon dshade 09/15/14 08:38:12 AM
#6844   Some say the blacker the berry the sweeter supergypsy 09/14/14 11:59:26 AM
#6843   Almost 1/4 of ONVO shares are shorted rumper 09/14/14 11:56:44 AM
#6842   Weird 7.3 million dollars Deff looking good standon23 09/13/14 07:14:50 PM
#6841   It was a purchase, or out of sequence dshade 09/12/14 07:06:09 PM
#6840   Are you sure they were purchases? They Alvie 09/12/14 06:09:27 PM
#6839   Whats with the two 500K share purchases AH?.. squashjohn 09/12/14 05:39:41 PM
#6838   It was quick typo. Been posted to him dshade 09/12/14 12:12:36 PM
#6837   I figured it out. You don't understand the RallyTheMarket 09/12/14 12:05:40 PM
#6836   you are. just click over on quote and dshade 09/12/14 12:01:10 PM
#6835   Guess we are still having issues here. RallyTheMarket 09/12/14 11:54:58 AM
#6834   add the dip just like June. let the dshade 09/12/14 11:51:06 AM
#6833   1 yr ONVO up 50% dshade 09/12/14 11:50:10 AM
#6832   The board knows. just a typo dshade 09/12/14 11:49:32 AM
#6831   I think the board needs a reminder. YTD RallyTheMarket 09/12/14 11:48:33 AM
#6830   Sorry. ONVO is up 50% for 1 year dshade 09/12/14 11:48:33 AM
#6829   Jan. 15th 2014 $11.61. So YTD 50% up? RallyTheMarket 09/12/14 11:40:06 AM
#6828   AND... a year from today, grantg2 09/12/14 11:10:45 AM
#6826   your subtle short is silly. posting repeatedly dshade 09/12/14 10:57:07 AM
#6825   ONVO 12/31/2013 11.07 Today 7.24 DOWN -35% rumper 09/12/14 10:30:24 AM
#6823   Go ahead and pick your fight. I don't grantg2 09/11/14 09:18:10 PM
#6822   Down 33% affects every share holder. rumper 09/11/14 09:03:54 PM
#6821   Running out of patience sounds like a PROBLEM grantg2 09/11/14 08:42:00 PM
#6820   At_7.40, that's down 33% for the year. rumper 09/11/14 08:34:49 PM
#6819   Pretty excited for the future of Organovo HennHouse 09/11/14 08:24:30 PM
#6818   Obviously SOME TRADERS are CAUGHT on the WRONG grantg2 09/11/14 07:05:11 PM
#6817   A_run_to_9, we'll only be down 18% this year! rumper 09/11/14 05:39:05 PM
#6816   just like June before run to $9 and dshade 09/11/14 03:51:43 PM
#6815   no, he said new information coming on next release dshade 09/11/14 03:28:36 PM
#6814   So nothing new? What about next conference call's RallyTheMarket 09/11/14 03:25:19 PM